| Name | Title | Contact Details |
|---|---|---|
Steve Killmeyer |
CFO | Profile |
Lisa Lucifero |
Vice President and Head of Human Resources | Profile |
David Dworaczyk |
Chief Executive Officer | Profile |
CareLink Community Services provides a progressive approach to rehabilitation, wellness, & autonomy for people with disabilities.
La Jolla Pharmaceutical Company is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases. The Company has four product candidates in development. LJPC-501 is La Jolla’s proprietary formulation of angiotensin II for the potential treatment of catecholamine-resistant hypotension and hepatorenal syndrome. GCS-100 is La Jolla’s first-in-class galectin-3 inhibitor for the potential treatment of chronic kidney disease. LJPC-1010, La Jolla’s second-generation galectin-3 inhibitor, is a more potent and purified derivative of GCS-100 that can be delivered orally for the potential treatment of nonalcoholic steatohepatitis and other diseases characterized by tissue fibrosis. LJPC-401 is La Jolla’s novel formulation of hepcidin for the potential treatment of conditions characterized by iron overload, such as hemochromatosis and beta thalassemia
Kane Veterinary Supplies Ltd. is a Edmonton, AB-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Tensentric has one focus: the design and development of medical devices. This narrow focus and expertise is tailored to meet the specific needs of each of our clients and lets us design as efficiently as possible. Tensentric is ISO13485:2003 certif...
XCELLENCE is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.